Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
The Wall Street Journal
Don’t Expand Payroll Taxes for Social Security
In his column “Republicans’ Pre-Emptive Social Security Surrender” (Political Economics, Sept. 18), Joseph C. Sternberg makes a persuasive argument against expanding…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Comment
CEI Comments on 340B Payment Change
The Competitive Enterprise Institute (CEI) submits these comments in support of several of the provisions in the rule recently proposed by CMS. Founded in…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…